EDESA BIOTECH INC (EDSA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:EDSA • CA27966L3065

1.09 USD
-0.05 (-4.39%)
At close: Feb 4, 2026
1.11 USD
+0.02 (+1.83%)
After Hours: 2/4/2026, 8:15:52 PM
Fundamental Rating

2

EDSA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 524 industry peers in the Biotechnology industry. EDSA has a great financial health rating, but its profitability evaluates not so good. EDSA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • EDSA had negative earnings in the past year.
  • EDSA had a negative operating cash flow in the past year.
  • In the past 5 years EDSA always reported negative net income.
  • In the past 5 years EDSA always reported negative operating cash flow.
EDSA Yearly Net Income VS EBIT VS OCF VS FCFEDSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • EDSA has a Return On Assets (-53.11%) which is in line with its industry peers.
  • The Return On Equity of EDSA (-57.71%) is better than 62.60% of its industry peers.
Industry RankSector Rank
ROA -53.11%
ROE -57.71%
ROIC N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
EDSA Yearly ROA, ROE, ROICEDSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EDSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EDSA Yearly Profit, Operating, Gross MarginsEDSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

7

2. Health

2.1 Basic Checks

  • The number of shares outstanding for EDSA has been increased compared to 1 year ago.
  • The number of shares outstanding for EDSA has been increased compared to 5 years ago.
  • EDSA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EDSA Yearly Shares OutstandingEDSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
EDSA Yearly Total Debt VS Total AssetsEDSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

  • EDSA has an Altman-Z score of -3.36. This is a bad value and indicates that EDSA is not financially healthy and even has some risk of bankruptcy.
  • EDSA has a Altman-Z score (-3.36) which is comparable to the rest of the industry.
  • EDSA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.36
ROIC/WACCN/A
WACCN/A
EDSA Yearly LT Debt VS Equity VS FCFEDSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 10.67 indicates that EDSA has no problem at all paying its short term obligations.
  • EDSA has a Current ratio of 10.67. This is amongst the best in the industry. EDSA outperforms 84.16% of its industry peers.
  • EDSA has a Quick Ratio of 10.67. This indicates that EDSA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 10.67, EDSA belongs to the top of the industry, outperforming 84.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.67
Quick Ratio 10.67
EDSA Yearly Current Assets VS Current LiabilitesEDSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

  • EDSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.05%, which is quite impressive.
EPS 1Y (TTM)30.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • EDSA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.03% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-34.99%
EPS Next 2Y-17.91%
EPS Next 3Y-1.03%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EDSA Yearly Revenue VS EstimatesEDSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 200K 400K 600K 800K 1M
EDSA Yearly EPS VS EstimatesEDSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EDSA. In the last year negative earnings were reported.
  • Also next year EDSA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDSA Price Earnings VS Forward Price EarningsEDSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDSA Per share dataEDSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.91%
EPS Next 3Y-1.03%

More info and screens

0

5. Dividend

5.1 Amount

  • EDSA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

EDESA BIOTECH INC

NASDAQ:EDSA (2/4/2026, 8:15:52 PM)

After market: 1.11 +0.02 (+1.83%)

1.09

-0.05 (-4.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)12-12
Earnings (Next)02-12
Inst Owners34.52%
Inst Owner Change-0.29%
Ins Owners12.23%
Ins Owner Change3.59%
Market Cap7.67M
Revenue(TTM)N/A
Net Income(TTM)-7.19M
Analysts82.5
Price Target11.22 (929.36%)
Short Float %0.28%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.36%
Min EPS beat(2)-17.65%
Max EPS beat(2)6.92%
EPS beat(4)2
Avg EPS beat(4)-15.56%
Min EPS beat(4)-51.8%
Max EPS beat(4)6.92%
EPS beat(8)6
Avg EPS beat(8)8.93%
EPS beat(12)10
Avg EPS beat(12)16.39%
EPS beat(16)14
Avg EPS beat(16)21.14%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.45%
EPS NQ rev (1m)-63.64%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.73
EV/EBITDA N/A
EPS(TTM)-1.35
EYN/A
EPS(NY)-1.82
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0
BVpS1.77
TBVpS1.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.11%
ROE -57.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-135.86%
ROA(5y)-111.64%
ROE(3y)-205.71%
ROE(5y)-157.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.67
Quick Ratio 10.67
Altman-Z -3.36
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.34%
EPS Next Y-34.99%
EPS Next 2Y-17.91%
EPS Next 3Y-1.03%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.31%
OCF growth 3YN/A
OCF growth 5YN/A

EDESA BIOTECH INC / EDSA FAQ

What is the fundamental rating for EDSA stock?

ChartMill assigns a fundamental rating of 2 / 10 to EDSA.


Can you provide the valuation status for EDESA BIOTECH INC?

ChartMill assigns a valuation rating of 0 / 10 to EDESA BIOTECH INC (EDSA). This can be considered as Overvalued.


What is the profitability of EDSA stock?

EDESA BIOTECH INC (EDSA) has a profitability rating of 1 / 10.


Can you provide the financial health for EDSA stock?

The financial health rating of EDESA BIOTECH INC (EDSA) is 7 / 10.


Can you provide the expected EPS growth for EDSA stock?

The Earnings per Share (EPS) of EDESA BIOTECH INC (EDSA) is expected to decline by -34.99% in the next year.